A survey was undertaken by the eClinical Forum to review the pharmaceutical industry’s experience to date with Electronic Data Capture (EDC) and to better understand future trends.

The survey report incorporates the responses of 30 companies, and includes a mixture of EU and US ethical pharmaceutical and biotechnology companies representing 8 of the top 10, 12 of the top 20 and 18 of the top 40 by revenue.

The survey assessed the positions of the respondents in the following areas:
* The electronic data collection technologies currently in use.
* The extent of internal and external development of systems.
* The percentage of clinical studies that have been conducted using EDC during the last 12 months.
* The expectations and achievements of EDC in the areas of development time, cost, quality and capacity.
* The areas of re-design that were conducted in parallel to the implementation of EDC.
* An assessment of EDC experience to date.
* EDC technologies being considered for future use.
* The percentage of future clinical trials that will be conducted.
* Issues with current vendor products and services.
* Issues and concerns with EDC.
* Additional information and experience.